
From left: Kevin Tabb, inaugural incumbent Marc Garnick and HMS Dean Jeffrey S. Flier. Image: Gretchen Ertl
Marc Garnick has been named the inaugural incumbent of the Gorman Brothers Professorship in Medicine in a ceremony in HMS’s New Research Building.
“Marc, you are an outstanding member of our faculty, an exceptional clinician and a very deserving inaugural incumbent for this great honor,” said Harvard Medical School Dean Jeffrey S. Flier.
Garnick has been an HMS faculty member for 35 years, starting at Brigham and Women’s Hospital, moving to Beth Israel Deaconess Medical Center in 1996 and becoming a full professor in 1998. An expert in oncology and urologic cancer, he has worked to develop new treatments for prostate cancer. He founded the Hershey Family Foundation for Prostate Cancer Research and is director of community cancer services at Beth Israel Deaconess Cancer Center.
Dedicated to helping patients and their families understand the medical complexities involved with determining their treatment plans, Garnick also has authored several journal articles on this topic.
Upon Garnick’s retirement, the professorship will be renamed the Gorman Brothers-Marc Garnick, M.D. Professorship in Medicine.
Other speakers at the May 2014 ceremony included Mark Zeidel, chair of the Department of Medicine and physician-in-chief at Beth Israel Deaconess and the Herrman L. Blumgart Professor of Medicine at HMS; Lowell Schnipper, clinical director of the Cancer Center and chief of the Division of Hematology and Oncology at Beth Israel Deaconess and the Theodore W. and Evelyn G. Berenson Professor of Medicine at HMS; and Kevin Tabb, president and CEO of Beth Israel Deaconess.
The professorship was made possible by Lisa, Leon, James, Maureen and Shawn Gorman, active members of the southern Maine business, oncological and Jewish communities.
The professorship is “a fitting tribute that will stand in perpetuity and forever support faculty incumbents at BIDMC in Marc’s and the Gorman family’s good names,” said Flier.